GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cereno Scientific AB (OSTO:CRNO B) » Definitions » Float Percentage Of Total Shares Outstanding

Cereno Scientific AB (OSTO:CRNO B) Float Percentage Of Total Shares Outstanding : 0.00% (As of May. 25, 2025)


View and export this data going back to 2016. Start your Free Trial

What is Cereno Scientific AB Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Cereno Scientific AB's float shares is 0.00 Mil. Cereno Scientific AB's total shares outstanding is 281.70 Mil. Cereno Scientific AB's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Cereno Scientific AB's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Cereno Scientific AB's Institutional Ownership is 0.02%.

Cereno Scientific AB Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Cereno Scientific AB's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/281.70
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cereno Scientific AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cereno Scientific AB (OSTO:CRNO B) » Definitions » Float Percentage Of Total Shares Outstanding
Comparable Companies
OSTO:EQL OSTO:ENZY OSTO:DICOT OSTO:ORX OSTO:CINPHA OSTO:MOB OSTO:NANEXA OSTO:ERMA OSTO:KLAR XSAT:ACUC ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD NSE:DIVISLAB HKSE:03692 XSWX:SDZ XTAE:TEVA
Traded in Other Exchanges
4A1:Germany
Address
BioVentureHub, Pepparedsleden 1, Molndal, SWE, 431 83
Website
https://www.cerenoscientific.se
Cereno Scientific AB is developing a pipeline of preventive therapeutics to treat cardiovascular and rare diseases by epigenetic modulation through histone deacetylase inhibition (HDACi). The company's lead program, CS1, is a phase two dual-acting antithrombotic drug aimed at venous thrombosis and stroke prevention for atrial fibrillation. Cereno Scientificalso evaluates the potential of epigenetic modulation for rare diseases related to pulmonary fibrosis, thrombosis, inflammation, and high blood pressure in the pulmonary circulation system.

Cereno Scientific AB Headlines

No Headlines